MD-clip trial
Completed
- Conditions
- Patients experiencing severe irreversible vision loss as a result of age-related macular degeneration (ARMD)
- Registration Number
- NL-OMON27967
- Lead Sponsor
- Erasmus Medical Center
- Brief Summary
Visser MS, Dieleman M, Klijn S, Timman R, Lundström M, Busschbach JJV & Reus NJ. Validation, test-retest reliability and norm scores for the Dutch Catquest-9SF. Acta Ophthalm. 2016;Oct 24. doi: 10.1111/aos.13287.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 160
Inclusion Criteria
diagnosis of age-related macular degeneration (AMD)
- aged at least 18 years
Exclusion Criteria
- insufficient capacities of the Dutch language
- handicaps impeding participation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome was quality of life as measured with the subscale distance activities and the composite scale of the NEI-VFQ-25
- Secondary Outcome Measures
Name Time Method Secondary outcomes were visual acuity (ETDRS) and contrast sensitivity (Pelli-Robson) measures with or with the MD-clip. Burden was measured using the EQ-5D-5